会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 51. 发明授权
    • Method to trigger RNA interference
    • 触发RNA干扰的方法
    • US08030473B2
    • 2011-10-04
    • US11334776
    • 2006-01-06
    • James C. CarringtonEdwards Allen
    • James C. CarringtonEdwards Allen
    • C12N15/113C12N15/63C12N15/82
    • C12N15/8279C12N15/111C12N15/113C12N15/8218C12N15/8245C12N15/8246C12N15/8247C12N15/8251C12N15/8261C12N15/8271C12N15/8274C12N15/8281C12N15/8283C12N15/8285C12N2310/14C12N2320/11
    • A method to generate siRNAs in vivo is described, as are constructs and compositions useful in the method. The method does not depend on the use of DNA or synthetic constructs that contain inverted duplications or dual promoters so as to form perfect or largely double-stranded RNA. Rather, the method depends on constructs that yield single-stranded RNA transcripts, and exploits endogenous or in vivo-produced miRNAs or siRNAs to initiate production of siRNAs. The miRNAs or siRNAs guide cleavage of the transcript and set the register for production of siRNAs (usually 21 nucleotides in length) encoded adjacent to the initiation cleavage site within the construct. The method results in specific formation of siRNAs of predictable size and register (phase) relative to the initiation cleavage site. The method can be used to produce specific siRNAs in vivo for inactivation or suppression of one or more target genes or other entities, such as pathogens.
    • 描述了在体内产生siRNA的方法,以及在该方法中有用的构建体和组合物。 该方法不依赖于使用含有反向重复或双重启动子的DNA或合成构建体,以形成完整或大部分双链RNA。 相反,该方法取决于产生单链RNA转录物的构建体,并利用内源或体内产生的miRNA或siRNA来引发siRNA的产生。 miRNA或siRNA指导转录物的切割,并设置用于生产与构建体内的起始切割位点相邻编码的siRNA(通常长度为21个核苷酸)的寄存器。 该方法导致相对于起始切割位点具有可预测大小和寄生(相)的siRNA的特异性形成。 该方法可用于在体内产生特异性siRNA以灭活或抑制一种或多种靶基因或其他实体,例如病原体。